Aldeyra Therapeutics, Inc. (ALDX)
0.6711
-0.02
(-3.29%)
USD |
NASDAQ |
Nov 18, 16:00
0.66
-0.01
(-1.65%)
After-Hours: 20:00
Aldeyra Therapeutics Shareholders Equity (Quarterly) : 35.22M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 35.22M |
| June 30, 2026 | 37.89M |
| March 31, 2026 | 42.16M |
| December 31, 2025 | 44.25M |
| September 30, 2025 | 49.24M |
| June 30, 2025 | 55.29M |
| March 31, 2025 | 63.60M |
| December 31, 2024 | 71.00M |
| September 30, 2024 | 85.10M |
| June 30, 2024 | 98.31M |
| March 31, 2024 | 113.42M |
| December 31, 2023 | 119.80M |
| September 30, 2023 | 123.01M |
| June 30, 2023 | 129.88M |
| March 31, 2023 | 137.24M |
| December 31, 2022 | 151.01M |
| September 30, 2022 | 162.19M |
| June 30, 2022 | 174.03M |
| March 31, 2022 | 190.69M |
| December 31, 2021 | 205.74M |
| September 30, 2021 | 219.67M |
| June 30, 2021 | 233.68M |
| March 31, 2021 | 126.07M |
| December 31, 2020 | 59.51M |
| September 30, 2020 | 69.17M |
| Date | Value |
|---|---|
| June 30, 2020 | 52.79M |
| March 31, 2020 | 43.47M |
| December 31, 2019 | 48.08M |
| September 30, 2019 | 50.88M |
| June 30, 2019 | 67.33M |
| March 31, 2019 | 78.48M |
| December 31, 2018 | 86.62M |
| September 30, 2018 | 28.60M |
| June 30, 2018 | 36.98M |
| March 31, 2018 | 36.00M |
| December 31, 2017 | 39.60M |
| September 30, 2017 | 45.90M |
| June 30, 2017 | 23.34M |
| March 31, 2017 | 28.00M |
| December 31, 2016 | 21.65M |
| September 30, 2016 | 25.67M |
| June 30, 2016 | 29.52M |
| March 31, 2016 | 20.53M |
| December 31, 2015 | 24.88M |
| September 30, 2015 | 28.70M |
| June 30, 2015 | 31.52M |
| March 31, 2015 | 13.83M |
| December 31, 2014 | 6.284M |
| September 30, 2014 | 8.264M |
| June 30, 2014 | 9.815M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Prime Medicine, Inc. | 8.437M |
| Oncolytics Biotech, Inc. | -7.503M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.529B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.38M |
| Total Liabilities (Quarterly) | 8.160M |
| Debt to Equity Ratio | 0.013 |
| Current Ratio | 5.369 |
| Net Debt Paydown Yield | 4.07% |